chartexchange

Actinium Pharmaceuticals Names Matt David CFO

RTTNews | Oct 15, 2026 7:41 AM EDT


(RTTNews) - Actinium Pharmaceuticals, Inc. (ATNM), a clinical-stage biopharmaceutical company developing targeted radiotherapies for cancer, said Thursday it has appointed Matt David as chief financial officer.

Read original article